Two academics from the College of Medical and Dental Sciences have been named as Highly Cited Researchers in a prestigious list of the world's leading scientific minds.
Two academics from the College of Medical and Dental Sciences have been named as Highly Cited Researchers in a prestigious list of the world’s leading scientific minds.
Published by Thomson Reuters, the high-impact list represents some of the world’s most influential scientists whose work has been consistently judged by their peers to be of particular significance.
The College academics earned the distinction by writing the greatest numbers of reports officially designated by Essential Science Indicators as Highly Cited Papers. This ranks them among the top 1% most cited for their subject field and year of publication between 2002 and 2012, earning them the mark of exceptional impact.
The College researchers featured are:
Consultant Cardiologist & Professor of Cardiovascular Medicine, Director – Haemostasis Thrombosis & Vascular Biology Unit, Cardiovascular and Respiratory Sciences
Professor Gregory YH Lip has had a major interest into the epidemiology of atrial fibrillation (AF), the commonest cardiac rhythm disorder, as well as the pathophysiology of thromboembolism in this arrhythmia. Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA2DS2-VASc and HAS-BLED scores for assessing stroke and bleeding risk respectively were first proposed and independently validated following his research and are now incorporated into major international management guidelines, including those from Europe, USA and the National Institute for Health and Care Excellence (NICE). In January 2014, Professor Lip was ranked by Expertscape as the world's leading expert in the understanding and treatment of AF.
View staff profile for Professor Gregory YH Lip
Professor of Molecular Virology, Deputy Head of School, School of Immunity and Infection
Professor Jane McKeating set up the hepatitis C virus (HCV) group at the Medical School in January 2005. Her research focuses on understanding the mechanism of hepatitis C virus (HCV) entry into the liver and how the virus persists to evade the innate and adaptive immune responses. Development of multi-cellular systems comprising hepatocytes and non-parenchymal liver cells have enabled Professor McKeating to uncover new pathways that regulate viral replication. Her group is exploring the impact of viral and bacterial co-infection on HCV pathogenesis and the role persistent HCV replication plays in the development of hepatocellular carcinoma. The group is involved in a wide range of local and international collaborative studies.
View staff profile for Professor Jane McKeating
